These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 467633)

  • 1. [Quinolozidinylalkylamines with antihypertensive activity].
    Boido V; Boido A; Boido-Canu C; Sparatore F
    Farmaco Sci; 1979 Aug; 34(8):673-87. PubMed ID: 467633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cardiovascular action of 1,2,4-benzothiadiazine-1,1-dioxide derivatives. VII].
    Di Bella M; Ferrari P; Pizzirani V; Parenti C; Raffa L
    Farmaco Sci; 1978 May; 33(5):350-9. PubMed ID: 738452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular activity of some substituted 2-aminobenzoquinolizines.
    Van Dyke JW; Havera HJ; Johnson RD; Vidrio H; Viveros A
    J Med Chem; 1972 Jan; 15(1):91-4. PubMed ID: 5007102
    [No Abstract]   [Full Text] [Related]  

  • 4. [Synthesis and pharmacodynamic properties of various lupinane derivatives].
    Sparatore F; Boido V; Preziosi P; Miele E; De Natale G
    Farmaco Sci; 1969 Jun; 24(6):587-621. PubMed ID: 4390006
    [No Abstract]   [Full Text] [Related]  

  • 5. Synthesis and antihypertensive activity evaluation of indole derivatives N-acetamido substituted.
    Grasso S; Molica C; Monforte AM; Monforte P; Zappalà M; Monforte MT; Trovato A
    Farmaco; 1995 Feb; 50(2):113-7. PubMed ID: 7766275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. U-54,669F: a novel hypotensive agent.
    Wendling MG; DuCharme DW; Johnson GA; McCall RB; Pals DT
    Fed Proc; 1983 Feb; 42(2):162-6. PubMed ID: 6822289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and pharmacological activity of some 1-lupinylbenzimidazoles and 1-lupinylbenzotriazoles.
    Boido A; Vazzana I; Sparatore F; Cenicola ML; Donnoli D; Marmo E
    Farmaco; 1991 Jun; 46(6):775-88. PubMed ID: 1772563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis and pharmacological screening of novel antihypertensive agents using hybrid approach.
    Bhandari SV; Bothara KG; Patil AA; Chitre TS; Sarkate AP; Gore ST; Dangre SC; Khachane CV
    Bioorg Med Chem; 2009 Jan; 17(1):390-400. PubMed ID: 19036593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on pyrazine derivatives. XXX. Synthesis of pyrazinylamino-1,3-diazacycloalkanes of potential circulatory activity.
    Foks H; Wisterowicz K; Damasiewicz B; Nasal A; Petrusewicz J; Radwańska A
    Acta Pol Pharm; 1997; 54(1):55-62. PubMed ID: 9415199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antihypertensive effects of a new dihydropyridine calcium antagonist.
    Kimura Y; Fukui H; Tanaka M; Okamoto M; Morino A; Miura A; Kimura K; Enomoto H
    Arzneimittelforschung; 1986 Sep; 36(9):1329-35. PubMed ID: 3790182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of dipeptidyl peptidase iv inhibition on arterial blood pressure.
    Jackson EK; Dubinion JH; Mi Z
    Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):29-34. PubMed ID: 18047624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular pharmacological characterization of novel 2,3-dimethyl-2-butylamine derivatives in rats.
    Chen YP; Qiu CR; Wang H
    Life Sci; 2004 Sep; 75(17):2131-42. PubMed ID: 15312756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Derivatives of 4,5,6,7-tetrahydro-7,8,8-trimethyl-3-phenylamino-4,7-methano-2H-ind azo le with hypotensive and hypoglycemic activities. II.
    Ranise A; Bondavalli F; Schenone P; Lampa E; Greco R; Scafuro M; Marmo E
    Farmaco Sci; 1984 Mar; 39(3):200-7. PubMed ID: 6714414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular effects of a new antihypertensive agent in several species.
    Salvati P; Caravaggi AM; Lamberti E; Monteggia M; Bianchi G
    Arzneimittelforschung; 1983; 33(8):1098-106. PubMed ID: 6685486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. General pharmacology of the novel centrally acting antihypertensive agent moxonidine.
    Armah BI; Hofferber E; Stenzel W
    Arzneimittelforschung; 1988 Oct; 38(10):1426-34. PubMed ID: 3196383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Derivatives of 1,3,3-trimethyl-6-azabicyclo[3.2.1]octane with hypotensive activity. II.
    Ranise A; Bondavalli F; Mariani E; Schenone P; Lampa E; Giordano L; Vacca C; Marmo E
    Farmaco Sci; 1983 Nov; 38(11):884-92. PubMed ID: 6653774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new centrally acting antihypertensive (ICI 106270) which separates antihypertensive effects from sedation.
    Clough DP; Hatton R; Pettinger SJ
    Arzneimittelforschung; 1981; 31(10):1698-703. PubMed ID: 7198445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and pharmacological evaluation of new 1-[3-(4-arylpiperazin-1-yl)-2-hydroxypropyl]-pyrrolidin-2-one derivatives with anti-arrhythmic, hypotensive, and alpha-adrenolytic activity.
    Kulig K; Sapa J; Maciag D; Filipek B; Malawska B
    Arch Pharm (Weinheim); 2007 Sep; 340(9):466-75. PubMed ID: 17806129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. General pharmacology of the novel angiotensin converting enzyme inhibitor alacepril. 1st communication: Effects on cardiovascular, visceral and renal functions and on blood.
    Matsuno Y; Taira N; Fujitani B; Ito T; Kadokawa T
    Arzneimittelforschung; 1986; 36(1):55-62. PubMed ID: 3513777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and structure-activity relationship of a new series of potent AT1 selective angiotensin II receptor antagonists: 5-(biphenyl-4-ylmethyl)pyrazoles.
    Almansa C; Gómez LA; Cavalcanti FL; de Arriba AF; García-Rafanell J; Forn J
    J Med Chem; 1997 Feb; 40(4):547-58. PubMed ID: 9046346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.